瑞他莫林——一种新的外用抗菌药
摘要
皮肤与软组织感染是皮肤科常见病,而细菌对常用的外用抗菌药物的耐药性正在全球范围内增加,这些药物包括莫匹罗星与夫西地酸。如金黄色葡萄球菌对莫匹罗星的耐药率在拉丁美洲为1.3%,欧洲为8.7%,美国为32.5%;凝血酶阴性的葡萄球菌对莫匹罗星的耐药率欧洲为12.7%,
出处
《中华皮肤科杂志》
CAS
CSCD
北大核心
2012年第2期147-149,共3页
Chinese Journal of Dermatology
参考文献17
-
1Jones RN,Fritsche TR,Sader HS,et al.Activity of retapamulin (SB-275833),a novel pleuromulin against selected gram-positive cocci.Antimicrob Agents Chemother,2006,50(7):2583-2586.
-
2Shah M,Mohanraj M.High levels of fusidic acid-resistant Staphylococcus aureus in dermatology patients.Br J Dermatol,2003,148(5):1018-1020.
-
3Pankuch GA,Lin G,Hoellman DB,et al.Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus,evaluated by agar dilution,microdilution,E-test,and disk diffusion methodologies.Antimicrob Agents Chemother,2006,50 (5):1727-1730.
-
4Scangarella-Oman N,Shawar RM,Bouchillon S,et al.Microbiological profile of a new topical antibacterial:retapamulin ointment 1%.Expert Rev Anti Infect Ther,2009,7(3):269-279.
-
5Traczewski MM,Brown SD.Proposed MIC and disk microbiological cutoffs and spectrum of activity of retapamulin,a novel topical antimicrobial agent.Antimicrob Agents Chemother,2008,52(11):3863-3867.
-
6Ross JE,Jones RN.Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methods.J Clin Microbiol,2005,43(12):6212-6213.
-
7McConeghy KW,Mikolich DJ,LaPlante KL.Agents for the decolonization of methicillin-resistant Staphylococcus aureus.Pharmacotherapy,2009,29(3):263-280.
-
8Champney WS,Rodgers WK.Retapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.Antimicrob Agents Chemother,2007,51 (9):3385-3387.
-
9Abramovits W,Gupta A,Gover M.Altabax (retapamulin ointment).1%.Skinmed,2007,6(5):239-240.
-
10Kosowska-Shik K,Clark C,Credito K,et al.Single-and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes.Antimicrob Agents Chemother,2006,50(2):765-769.
二级参考文献3
-
1Odou M F, Miler C, Calvet L, et al. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections. J Antimicrob Chemother,2007,59:646.
-
2Free A, Both E, Dalessandro M, et al. Retapamulin ointment twice daily for 5 days vs oral cephalexin twice daily for 10 days for empiric treatment of secondarily infected traumatic lesions of the skin. Skinmed, 2006,5 : 224.
-
3Parish L C, Jorizzo J L, Breton J J, et al. Topical retapamulin ointment ( 1% wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in lhe treatment of secondarily infected dermatitis: resets of a randomized controlled trial. J Am Aead Dermatol,2006,55:1003.
共引文献8
-
1吴春丽,覃春菀,张俊霞,史云涛.菌渣中截短侧耳素含量的高效液相色谱法测定[J].郑州大学学报(医学版),2009,44(1):178-180. 被引量:3
-
2王力强,冯文化,张越.截短侧耳素类抗生素Retapamulin的合成工艺改进[J].合成化学,2011,19(4):554-556. 被引量:1
-
3赵喜,王新杨,黄金华,凌勇.新型截短侧耳素衍生物的体外抗菌活性研究[J].交通医学,2013,27(2):129-130. 被引量:1
-
4吴阳阳,祝宏,唐志焱.截短侧耳素水杨酰正丁胺醚的合成和生物活性[J].农药,2014,53(6):405-407.
-
5郑小玲,王征南,李珏.瑞他莫林软膏的微生物限度检查适用性试验[J].中国现代应用药学,2016,33(5):634-637. 被引量:9
-
6吴毅武,朱称水,江婵,翟睿.瑞他莫林的合成研究[J].合成材料老化与应用,2017,46(4):79-82.
-
7丁超月,徐艳,孙丽,王兴宇,王宗朝,袁欣怡,瞿玮,潘源虎.截短侧耳素类抗生素及其耐药研究进展[J].国外医药(抗生素分册),2023,44(3):166-172. 被引量:1
-
8马剑锋,张小军,陈雪昌,严忠雍,宗婧婧,曾军杰.超高效液相色谱-串联质谱法测定水产品中瑞他莫林的残留量[J].理化检验(化学分册),2019,55(9):1008-1012.
-
1张伶俐.儿童药物不良反应监测系统的实践探索[J].药物不良反应杂志,2016,18(2):81-82. 被引量:1
-
2黄火明,郝群,李鸿雁,周伟澄.瑞他莫林的合成[J].中国医药工业杂志,2014,45(12):1101-1103. 被引量:2
-
3拉丁美洲:小型药房的艰难岁月[J].中国药店,2009(2):40-41.
-
4郑小玲,王征南,李珏.瑞他莫林软膏的微生物限度检查适用性试验[J].中国现代应用药学,2016,33(5):634-637. 被引量:9
-
5孙桂霞.1%盐酸特比萘芬乳膏治疗体、股癣疗效观察[J].中华今日医学杂志,2003,3(24):8-9. 被引量:1
-
6谢景超.抗菌药物耐药性的演变动向[J].中南药学,2003,1(1):46-49. 被引量:3
-
7王茜.截短侧耳素类抗生素的专利分析[J].生物技术世界,2015,12(4):159-159. 被引量:2
-
8李思温,吴玲娟,张绍基,徐明生,林丹丹,戴裕海,刘志德,易志辉,刘旭.青蒿琥酯预防日本血吸虫病系列研究报告[J].浙江省医学科学院学报,2005,16(2):153-158. 被引量:6
-
9施桂兰(摘).GSK公司申请上市Cervarix[J].国外药讯,2006(10):28-28.
-
10王普善.世界制药工业面临的新挑战[J].中国制药信息,2006,22(5):3-10.